Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27. 2008

Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
State Key Laboratory of Experimental Hematology, Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, 288 Nanjing Road, Tianjin 300020, PR China.

Interleukin-27 (IL-27) is an IL-12-related cytokine that can promote both anti- and pro-inflammatory immune responses. In this study, we used the promonocytic cell line THP-1, an established model for monocytes to investigate if the immunoregulatory role of IL-27 is in part due to effects on major histocompatibility complex (MHC) Ag presentation. We find that IL-27 induces mRNA and surface expression of class II MHC in THP-1 cells. IL-27 also increases class I MHC heavy chain, beta2m, and TAP-1 transcripts, leading to an increased surface expression of class I MHC. In addition, IL-27 enhances expression of costimulatory molecules CD80 and CD86 and adhesion molecule CD54. Expression of the class II transactivator (CIITA) isoforms III and IV, but not I, transcripts increases in response to IL-27. Our data suggest that the pro-inflammatory role of IL-27 is mediated in part through increased expression of key molecules involved in the class II and class I MHC pathways.

UI MeSH Term Description Entries
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I
D015534 Trans-Activators Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins. Nuclear Trans-Acting Factor,Trans-Acting Factors,Trans-Acting Factor,Trans-Activator,Transactivator,Transactivators,Factor, Nuclear Trans-Acting,Factor, Trans-Acting,Factors, Trans-Acting,Nuclear Trans Acting Factor,Trans Acting Factor,Trans Acting Factors,Trans Activator,Trans Activators,Trans-Acting Factor, Nuclear
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D050856 Interferon Regulatory Factor-1 An interferon regulatory factor that binds upstream TRANSCRIPTIONAL REGULATORY ELEMENTS in the GENES for INTERFERON-ALPHA and INTERFERON-BETA. It functions as a transcriptional activator for the INTERFERON TYPE I genes. IRF-1 Transcription Factor,IREBF1 Protein,IREBF1 Transcription Factor,IRF-1 Protein,ISGF1 Transcription Factor,Interferon-Stimulated Gene Factor 1,MyD32 Protein,Factor, IRF-1 Transcription,Factor, ISGF1 Transcription,IRF 1 Protein,IRF 1 Transcription Factor,Interferon Regulatory Factor 1,Interferon Stimulated Gene Factor 1,Transcription Factor, IREBF1,Transcription Factor, IRF-1,Transcription Factor, ISGF1

Related Publications

Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
February 1998, Immunopharmacology and immunotoxicology,
Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
December 1999, Hematological oncology,
Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
June 1989, Agents and actions,
Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
September 2020, Developmental and comparative immunology,
Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
January 2014, Journal of toxicology and environmental health. Part A,
Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
August 1993, The Journal of biological chemistry,
Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
March 2009, Evidence-based complementary and alternative medicine : eCAM,
Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
June 1996, Acta medica Okayama,
Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
May 2003, Journal of biochemistry,
Xiao Ming Feng, and Na Liu, and Shao Guang Yang, and Li Yan Hu, and Xiao Li Chen, and Zhi Hong Fang, and Qian Ren, and Shi Hong Lu, and Bin Liu, and Zhong Chao Han
August 2001, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!